Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 16 May 1986:
Vol. 232. no. 4752, pp. 881 - 884
DOI: 10.1126/science.3085218
Prev | Table of Contents | Next

Articles

Science, Vol 232, Issue 4752, 881-884
Copyright © 1986 by American Association for the Advancement of Science

articles

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon

A Ferreira, L Schofield, V Enea, H Schellekens, P van der Meide, WE Collins, RS Nussenzweig, and V Nussenzweig

A specific DNA probe was used to study the effect of recombinant rat, mouse, and human gamma-interferon (gamma-IFN) on the course of sporozoite-induced malaria infections. In mice and rats infected with sporozoites of Plasmodium berghei, mouse and rat gamma-IFN's strongly inhibited the development of the exoerythrocytic forms in the liver liver cells of the hosts, but not the development of the erythrocytic stages. The degree of inhibition of the exoerythrocytic forms was proportional to the dose of gamma-IFN administered, but was independent of the number of sporozoites used for challenge. A 30 percent reduction in the development of exoerythrocytic forms in rat liver was achieved when 150 units (about 15 nanograms of protein) of rat gamma-IFN were injected a few hours before sporozoite challenge; the reduction was 90 percent or more with higher doses of gamma-IFN. The effect was less pronounced if the gamma-IFN was administered 18 hours before or a few hours after challenge. Human gamma-IFN also diminished the parasitemia in chimpanzees infected with sporozoites of the human malaria parasite Plasmodium vivax. The target of gamma-IFN activity may be the infected hepatocytes themselves, as shown by in vitro experiments in which small doses of the human lymphokine inhibited the development of exoerythrocytic forms of Plasmodium berghei in a human hepatoma cell line. These results suggest that immunologically induced interferon may be involved in controlling malaria infection under natural conditions.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Effector CD8+ T Lymphocytes against Liver Stages of Plasmodium yoelii Do Not Require Gamma Interferon for Antiparasite Activity.
S. Chakravarty, G. C. Baldeviano, M. G. Overstreet, and F. Zavala (2008)
Infect. Immun. 76, 3628-3631
   Abstract »    Full Text »    PDF »
Class II-Restricted Protective Immunity Induced by Malaria Sporozoites.
G. A. Oliveira, K. A. Kumar, J. M. Calvo-Calle, C. Othoro, D. Altszuler, V. Nussenzweig, and E. H. Nardin (2008)
Infect. Immun. 76, 1200-1206
   Abstract »    Full Text »    PDF »
A Linear Peptide Containing Minimal T- and B-Cell Epitopes of Plasmodium falciparum Circumsporozoite Protein Elicits Protection against Transgenic Sporozoite Challenge.
J. M. Calvo-Calle, G. A. Oliveira, C. O. Watta, J. Soverow, C. Parra-Lopez, and E. H. Nardin (2006)
Infect. Immun. 74, 6929-6939
   Abstract »    Full Text »    PDF »
NK Cell Responses to Plasmodium Infection and Control of Intrahepatic Parasite Development.
J. Roland, V. Soulard, C. Sellier, A.-M. Drapier, J. P. Di Santo, P.-A. Cazenave, and S. Pied (2006)
J. Immunol. 177, 1229-1239
   Abstract »    Full Text »    PDF »
Human CD4+ T Cells Induced by Synthetic Peptide Malaria Vaccine Are Comparable to Cells Elicited by Attenuated Plasmodium falciparum Sporozoites.
J. M. Calvo-Calle, G. A. Oliveira, and E. H. Nardin (2005)
J. Immunol. 175, 7575-7585
   Abstract »    Full Text »    PDF »
Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial.
G. A. Oliveira, K. Wetzel, J. M. Calvo-Calle, R. Nussenzweig, A. Schmidt, A. Birkett, F. Dubovsky, E. Tierney, C. H. Gleiter, G. Boehmer, et al. (2005)
Infect. Immun. 73, 3587-3597
   Abstract »    Full Text »    PDF »
Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes.
E. H. Nardin, G. A. Oliveira, J. M. Calvo-Calle, K. Wetzel, C. Maier, A. J. Birkett, P. Sarpotdar, M. L. Corado, G. B. Thornton, and A. Schmidt (2004)
Infect. Immun. 72, 6519-6527
   Abstract »    Full Text »    PDF »
Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1{beta}), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe Plasmodium falciparum Malaria and Matched Uncomplicated Malaria or Healthy Controls.
K. E. Lyke, R. Burges, Y. Cissoko, L. Sangare, M. Dao, I. Diarra, A. Kone, R. Harley, C. V. Plowe, O. K. Doumbo, et al. (2004)
Infect. Immun. 72, 5630-5637
   Abstract »    Full Text »    PDF »
A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
E. Prieur, S. C. Gilbert, J. Schneider, A. C. Moore, E. G. Sheu, N. Goonetilleke, K. J. H. Robson, and A. V. S. Hill (2004)
PNAS 101, 290-295
   Abstract »    Full Text »    PDF »
Transfected Plasmodium knowlesi Produces Bioactive Host Gamma Interferon: a New Perspective for Modulating Immune Responses to Malaria Parasites.
H. Ozwara, J. A. M. Langermans, C. H. M. Kocken, A. van der Wel, P. H. van der Meide, R. A. W. Vervenne, J. M. Mwenda, and A. W. Thomas (2003)
Infect. Immun. 71, 4375-4381
   Abstract »    Full Text »    PDF »
ASSOCIATION OF INTERFERON-{gamma} RESPONSES TO PRE-ERYTHROCYTIC STAGE VACCINE CANDIDATE ANTIGENS OF PLASMODIUM FALCIPARUM IN YOUNG KENYAN CHILDREN WITH IMPROVED HEMOGLOBIN LEVELS: XV. ASEMBO BAY COHORT PROJECT.
J. M. O. ONG'ECHA, A. A. LAL, D. J. TERLOUW, F. O. TER KUILE, S. K. KARIUKI, V. UDHAYAKUMAR, A. S. S. ORAGO, A. W. HIGHTOWER, B. L. NAHLEN, and Y. P. SHI (2003)
Am J Trop Med Hyg 68, 590-597
   Abstract »    Full Text »    PDF »
Transformation of Sporozoites into Early Exoerythrocytic Malaria Parasites Does Not Require Host Cells.
K. Kaiser, N. Camargo, and S. H.I. Kappe (2003)
J. Exp. Med. 197, 1045-1050
   Abstract »    Full Text »    PDF »
EX VIVO INTERFERON-GAMMA IMMUNE RESPONSE TO THROMBOSPONDIN-RELATED ADHESIVE PROTEIN IN COASTAL KENYANS: LONGEVITY AND RISK OF PLASMODIUM FALCIPARUM INFECTION.
K. L. FLANAGAN, T. MWANGI, M. PLEBANSKI, K. ODHIAMBO, A. ROSS, E. SHEU, M. KORTOK, B. LOWE, K. MARSH, and A. V. S. HILL (2003)
Am J Trop Med Hyg 68, 421-430
   Abstract »    Full Text »    PDF »
A Modified Hepatitis B Virus Core Particle Containing Multiple Epitopes of the Plasmodium falciparum Circumsporozoite Protein Provides a Highly Immunogenic Malaria Vaccine in Preclinical Analyses in Rodent and Primate Hosts.
A. Birkett, K. Lyons, A. Schmidt, D. Boyd, G. A. Oliveira, A. Siddique, R. Nussenzweig, J. M. Calvo-Calle, and E. Nardin (2002)
Infect. Immun. 70, 6860-6870
   Abstract »    Full Text »    PDF »
Malaria vaccines.
V. Moorthy and A. V S Hill (2002)
Br. Med. Bull. 62, 59-72
   Abstract »    Full Text »    PDF »
The Role of IL-18 in Blood-Stage Immunity Against Murine Malaria Plasmodium yoelii265 and Plasmodium bergheiANKA.
R. P. Singh, S.-i. Kashiwamura, P. Rao, H. Okamura, A. Mukherjee, and V. S. Chauhan (2002)
J. Immunol. 168, 4674-4681
   Abstract »    Full Text »    PDF »
Unique T Cell Effector Functions Elicited by Plasmodium falciparum Epitopes in Malaria-Exposed Africans Tested by Three T Cell Assays.
K. L. Flanagan, E. A. M. Lee, M. B. Gravenor, W. H. H. Reece, B. C. Urban, T. Doherty, K. A. Bojang, M. Pinder, A. V. S. Hill, and M. Plebanski (2001)
J. Immunol. 167, 4729-4737
   Abstract »    Full Text »    PDF »
Immunogenicity of Well-Characterized Synthetic Plasmodium falciparum Multiple Antigen Peptide Conjugates.
M. B. Joshi, A. A. Gam, R. A. Boykins, S. Kumar, J. Sacci, S. L. Hoffman, H. L. Nakhasi, and R. T. Kenney (2001)
Infect. Immun. 69, 4884-4890
   Abstract »    Full Text »    PDF »
Inhibition of Plasmodium yoelii blood-stage malaria by interferon {alpha} through the inhibition of the production of its target cell, the reticulocyte.
A. M. Vigario, E. Belnoue, A. Cumano, M. Marussig, F. Miltgen, I. Landau, D. Mazier, I. Gresser, and L. Renia (2001)
Blood 97, 3966-3971
   Abstract »    Full Text »    PDF »
Interleukin-12- and Gamma Interferon-Dependent Protection against Malaria Conferred by CpG Oligodeoxynucleotide in Mice.
R. A. Gramzinski, D. L. Doolan, M. Sedegah, H. L. Davis, A. M. Krieg, and S. L. Hoffman (2001)
Infect. Immun. 69, 1643-1649
   Abstract »    Full Text »    PDF »
DNA Immunization by Plasmodium falciparum Liver-Stage Antigen 3 Induces Protection against Plasmodium yoelii Sporozoite Challenge.
J.-P. Sauzet, B.-L. Perlaza, K. Brahimi, P. Daubersies, and P. Druilhe (2001)
Infect. Immun. 69, 1202-1206
   Abstract »    Full Text »    PDF »
A Totally Synthetic Polyoxime Malaria Vaccine Containing Plasmodium falciparum B Cell and Universal T Cell Epitopes Elicits Immune Responses in Volunteers of Diverse HLA Types.
E. H. Nardin, J. M. Calvo-Calle, G. A. Oliveira, R. S. Nussenzweig, M. Schneider, J.-M. Tiercy, L. Loutan, D. Hochstrasser, and K. Rose (2001)
J. Immunol. 166, 481-489
   Abstract »    Full Text »    PDF »
Host-Virus Interactions during Malaria Infection in Hepatitis B Virus Transgenic Mice.
V. Pasquetto, L. G. Guidotti, K. Kakimi, M. Tsuji, and F. V. Chisari (2000)
J. Exp. Med. 192, 529-536
   Abstract »    Full Text »    PDF »
alpha -Galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.
G. Gonzalez-Aseguinolaza, C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, et al. (2000)
PNAS 97, 8461-8466
   Abstract »    Full Text »    PDF »
Liver CD4-CD8- NK1.1+ TCR{alpha}{beta} Intermediate Cells Increase During Experimental Malaria Infection and Are Able to Exhibit Inhibitory Activity Against the Parasite Liver Stage In Vitro.
S. Pied, J. Roland, A. Louise, D. Voegtle, V. Soulard, D. Mazier, and P.-A. Cazenave (2000)
J. Immunol. 164, 1463-1469
   Abstract »    Full Text »    PDF »
Analysis of Immune Responses against T- and B-Cell Epitopes from Plasmodium falciparum Liver-Stage Antigen 1 in Rodent Malaria Models and Malaria-Exposed Human Subjects in India.
S. K. Joshi, A. Bharadwaj, S. Chatterjee, and V. S. Chauhan (2000)
Infect. Immun. 68, 141-150
   Abstract »    Full Text »    PDF »
Transforming Growth Factor beta  Production Is Inversely Correlated with Severity of Murine Malaria Infection.
F. M. Omer and E. M. Riley (1998)
J. Exp. Med. 188, 39-48
   Abstract »    Full Text »    PDF »
Effect of Interferon Gamma on Infection-Related Death in Patients With Severe Injuries: A Randomized, Double-blind, Placebo-Controlled Trial.
D. J. Dries, G. J. Jurkovich, R. V. Maier, T. P. Clemmer, S. N. Struve, J. A. Weigelt, G. G. Stanford, D. L. Herr, H. R. Champion, F. R. Lewis, et al. (1994)
Arch Surg 129, 1031-1041
   Abstract »    PDF »
Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer.
E. Nardin, D. Herrington, J Davis, M Levine, D Stuber, B Takacs, P Caspers, P Barr, R Altszuler, P Clavijo, et al. (1989)
Science 246, 1603-1606
   Abstract »    PDF »
Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes.
S. Hoffman, D Isenbarger, G. Long, M Sedegah, A Szarfman, L Waters, M. Hollingdale, P. van der Meide, D. Finbloom, and W. Ballou (1989)
Science 244, 1078-1081
   Abstract »    PDF »
Malaria vaccine trials.
R. Nussenzweig and V Nussenzweig (1988)
Science 241, 1278
   PDF »
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.
J. Sadoff, W. Ballou, L. Baron, W. Majarian, R. Brey, W. Hockmeyer, J. Young, S. Cryz, J Ou, G. Lowell, et al. (1988)
Science 240, 336-338
   Abstract »    PDF »
Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial Challenge.
H. W. MURRAY (1988)
Ann Intern Med 108, 595-608
   Abstract »    PDF »
Research toward malaria vaccines.
L. Miller, R. Howard, R Carter, M. Good, V Nussenzweig, and R. Nussenzweig (1986)
Science 234, 1349-1356
   Abstract »    PDF »
Exploring the transcriptome of the malaria sporozoite stage.
S. H. I. Kappe, M. J. Gardner, S. M. Brown, J. Ross, K. Matuschewski, J. M. Ribeiro, J. H. Adams, J. Quackenbush, J. Cho, D. J. Carucci, et al. (2001)
PNAS 98, 9895-9900
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)